Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.877
Delayed Data
As of 4:00pm ET
 +0.0427 / +5.12%
Today’s Change
0.80
Today|||52-Week Range
7.75
-72.45%
Year-to-Date
No recent news for MannKind Corp.

Today’s Trading

Previous close0.83
Today’s open0.85
Day’s range0.80 - 0.92
Volume1,764,626
Average volume (3 months)1,535,908
Market cap$79.9M
Dividend yield--
Data as of 4:00pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-163.97%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio0.6
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SNSSSunesis Pharmaceutic...-0.04-1.07%
LIFEaTyr Pharma Inc+0.10+2.94%
RGLSRegulus Therapeutics...+0.05+3.23%
NVETNexvet Biopharma plc+0.00+0.08%
Data as of 4:00pm ET, 04/27/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director &
Vice President
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts